ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 143 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | -95.2% | 600 | -96.5% | 0.00% | – |
| Q3 2018 | $63,000 | – | 17,239 | +9584.8% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 178 | -99.4% | 0.00% | -100.0% |
| Q1 2018 | $103,000 | +930.0% | 27,963 | +669.7% | 0.01% | – |
| Q4 2017 | $10,000 | +900.0% | 3,633 | +742.9% | 0.00% | – |
| Q3 2017 | $1,000 | -92.3% | 431 | -86.8% | 0.00% | -100.0% |
| Q1 2017 | $13,000 | -95.0% | 3,271 | -89.9% | 0.00% | -94.4% |
| Q3 2016 | $262,000 | +98.5% | 32,439 | +90.7% | 0.02% | +100.0% |
| Q2 2016 | $132,000 | +193.3% | 17,009 | +188.6% | 0.01% | +125.0% |
| Q1 2016 | $45,000 | -85.0% | 5,893 | -78.8% | 0.00% | -82.6% |
| Q4 2015 | $300,000 | +3650.0% | 27,853 | +2742.1% | 0.02% | +2200.0% |
| Q2 2015 | $8,000 | -92.5% | 980 | -91.0% | 0.00% | -91.7% |
| Q1 2015 | $106,000 | -48.3% | 10,832 | -35.4% | 0.01% | -52.0% |
| Q4 2014 | $205,000 | – | 16,766 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |